학술논문
Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: Efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial
Document Type
Article
Author
Source
In: Archives of Dermatology . (Archives of Dermatology, April 2011, 147(4):429-436)
Subject
Language
English
ISSN
0003987X
15383652
15383652